Article Text
Therapeutics/Prevention
Randomised controlled trial
High-sensitivity troponin predicts coronary disease outcomes in type 2 diabetes but yields no benefit in selecting patients for revascularisation
Statistics from Altmetric.com
Footnotes
Contributors JJ drafted the manuscript of this commentary.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.